Further analysis of anti-LAIR1–treated GBM revealed that there were fewer M2-like TAMs and lower expression of M2-like TAM signature genes, including F13a1, which encodes factor XIII-A (FXIII-A). The gene discussed is F13A1; the disease is glioblastoma.